Insider Selling: NxStage Medical, Inc. (NXTM) SVP Sells 3,500 Shares of Stock
NxStage Medical, Inc. (NASDAQ:NXTM) SVP Winifred L. Swan sold 3,500 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $24.48, for a total transaction of $85,680.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Shares of NxStage Medical, Inc. (NXTM) traded down $0.25 during midday trading on Thursday, hitting $24.13. 252,846 shares of the stock were exchanged, compared to its average volume of 540,906. The firm has a market cap of $1,600.00, a P/E ratio of 41.60 and a beta of -0.08. NxStage Medical, Inc. has a fifty-two week low of $20.45 and a fifty-two week high of $30.80.
A number of research firms have commented on NXTM. Zacks Investment Research downgraded shares of NxStage Medical from a “hold” rating to a “sell” rating in a report on Tuesday, February 13th. BidaskClub downgraded shares of NxStage Medical from a “sell” rating to a “strong sell” rating in a report on Thursday, February 15th. Northland Securities restated a “hold” rating and set a $30.00 price target on shares of NxStage Medical in a report on Wednesday, November 8th. Finally, ValuEngine downgraded shares of NxStage Medical from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Three analysts have rated the stock with a sell rating and eight have issued a hold rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $30.25.
About NxStage Medical
NxStage Medical, Inc is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets.
Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.